Skip to main content
Caplight Logo









Cure Parkinson's

Cure Parkinson's

Overview

Cure Parkinson's is a UK-based charity that funds research to find a cure for Parkinson's disease. It focuses on identifying, funding, and evaluating research projects with the potential to slow, stop, or reverse the progression of the condition.

Year Founded

2005

Portfolio Companies

1

Investments

Cure Parkinson's investments
CompanyDateStageLead
Olatec TherapeuticsFeb 2024GrantLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Cure Parkinson's based?

Cure Parkinson's is headquartered in London, United Kingdom.

When was Cure Parkinson's founded?

Cure Parkinson's was founded in 2005.

How many portfolio companies does Cure Parkinson's have?

Cure Parkinson's has 1 portfolio company in Caplight's dataset.

What are some companies in Cure Parkinson's's portfolio?

Portfolio companies visible on Caplight include Olatec Therapeutics.

What was Cure Parkinson's's most recent investment shown here?

Cure Parkinson's's most recent investment in this portfolio sample was in Olatec Therapeutics in 2024.

What sectors does Cure Parkinson's focus on?

Cure Parkinson's focuses on Healthcare & Life Sciences.

What company stages does Cure Parkinson's focus on?

Stage focus information for Cure Parkinson's is not publicly available.

Firmographic Details

HeadquartersLondon
Year Founded2005

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?